Glucose Kabi 30% Fresenius Kabi injection is severe hypoglycemia (50 pipes x 5ml)

Dosage form Box of 50 tubes
Specifications Glucose

Ingredient

Composition informationContent
Glucose1.5

Uses

Indications

The drug is indicated in the following cases:

  • Emergency treatment cases of severe hypoglycemia.
  • Carbon deficiency treatment.
  • Pharmacy

    glucose is a single 6 -carbon line, using intravenously to treat glucose deficiency and fluid. Glucose injection solution is often used to provide energy for patients and use with electrolyte solutions to prevent and treat dehydration due to acute diarrhea. Glucose is also used to treat hypoglycemia and make other drugs. 30% hypertonic glucose solution is often used to provide carbon hydrate.

    pharmacokinetics

    glucose converted into carbon dioxide and water, and release energy.

    Before taking Glucose Kabi 30% Fresenius Kabi injection is severe hypoglycemia (50 pipes x 5ml)

    How to use

    peripheral intravenous injection slowly from 5ml - 20ml/time as directed by the physician.

    Dosage

    Dosage depending on the age, weight, clinical condition of each patient. Must closely monitor the patient's blood glucose.

    The maximum dosage of glucose recommended is 0.5 g of glucose/kg body weight/hour (equivalent to 1.7m/kg body weight/hour).

    Note: The hypertonic solution must be injected very slowly.

    Prevention when taking drugs

    Use only once, remove the redundant after use.

    Injecting types of injections should be checked for sub -fertilizers and discoloration before injection, check the intactness of the packaging, only use if the solution is clear, there are no visible stools, the packaging is not damaged.

    The supplement of electrolytes should follow the clinical needs of each patient.

    Control

    Treatment should be performed under regular and careful supervision. Clinical and biological parameters, especially blood glucose, fluid and electrolytes should be monitored regularly and during treatment.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

    What to do when overdose?

    Expression

    Hyperglycemia, ureter glucose, osmotic diuretic (due to hyperglycemia), fluid balancing disorders, electrolytes.

    Handling

    Reducing the dose of glucose, insulin injection, water and electrolyte balance adjustment, strict control of parameters.

    What to do when forgetting a dose?

    Side Effects

    When using 30% Kabi Glucose Bidiphar 50 pipe x 5ml, you may experience unwanted effects (ADR).

    Common, ADR> 1/100

  • In place: In the spot pain, especially when using hypertonic glucose solution, there is often a low pH, intravenous irritation, intravenous inflammation, necrosis of the injection if the drug is released.
  • Uncommon, 1/1000

  • Water and electrolyte: Water and electrolyte disorders (hypotension, hypoglycemia, hypoglycemia).
  • Rare, ADR

  • Water and electrolyte: Dehydration as a result of high blood glucose.
  • Instructions on how to handle ADR

    When encountering any unwanted effects of the drug, consulting a doctor, pharmacist.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Glucose Kabi 30% Bidiphar 50 pipe x 5ml contraindicated in the following cases:

  • Patients with glucose intolerance.
  • dehydration if not enough electrolytes.
  • delirium with dehydration, alcohol poisoning.
  • Absolutely not used for patients after a stroke.

    water.

    Hypotension.

  • Increased coma.
  • Acute infection.
  • Animal.
  • Bleeding in the skull or in the spinal cord.
  • Do not get a hypertonic glucose solution for patients who are dehydrated due to dehydration will worsen due to osmotic gums.
  • Precautions when using

    dilution and other effects on serum electrolytes:

    Depending on the factors: injection volume, injection speed, clinical condition, patient glucose metabolism, glucose injection may cause:

    Increased osmotic pressure, osmotic, dehydration.

    Reduce osmotic pressure.

    electrolyte disorders such as hypoglycemia, hypotension, hypoglycemia, hypoglycemia.

    water stasis, increased circulatory volume, obstructive condition including pulmonary obstruction, edema.

    The above effects are the result of transmitting solutions that do not contain electrolytes, including glucose solution transmission.

    Hypoglycemia can develop into acute brain disease characterized by headache, nausea, seizures, coma, brain edema and death.

    Children, the elderly, women, patients after surgery, patients with oxygen deficiency, patients with disease on the central nervous system, patients with psychological thirst are at risk of these complications.

    Clinical and periodic assessments are necessary to control changes in fluid balance, electrolyte levels, acid-base whenever the patient's conditions or the treatment process ensure that assessment.

    Should be careful in patients at risk of water and electrolyte disorders and electrolytes may be worse due to increased free water load, increased blood glucose, may be required to use insulin.

    Hyperglycemia:

    Glucose intravenous injection must be cautious in the following patients:

    weakening glucose tolerance (patients with renal failure, diabetes, blood infections, trauma, shock).

    Severe malnutrition (due to the risk of re -feeding syndrome).

    Thiamin deficiency as in chronic alcoholic patients (the risk of severe lactic acidosis due to pyruvat oxidation).

    Patients with stroke due to ischemia, serious brain injury.

    Avoid injection within the first 24 hours after the first injury. Strict blood sugar monitoring due to early hyperglycemia is related to poor response in patients with serious brain injury.

    infants.

    Impact on insulin secretion:

    Extended intravenous injection and related hyperglycemia can cause insulin secretion stimulated by glucose.

    Hypersensitivity reaction:

    Hypersensitivity reactions include reported anaphylactic reaction. Injecting glucose solution should be cautious in patients with allergies to corn and corn products. The injection must be stopped immediately if there is any symptom of hypersensitivity reaction. Appropriate treatment according to clinical symptoms.

    Feeding syndrome:

    Restoration in patients with severe malnutrition can lead to feeding syndrome is characterized by the change of potassium, phosphorus, magnesium in cells due to the patient becoming assimilated. Thiamin and fluid deficiencies can also occur. It is necessary to carefully monitor and slowly increase the nutritional dose while avoiding excessive feeding can prevent complications.

    Liver disorders:

    Bile disorders include bile stasis, fatty liver, fibrosis and cirrhosis, which can lead to liver failure, cholecystitis, gallstones that have been recorded in some patients using intravenous nutrition. The cause of this disorder is due to many factors and differences between patients. Patients with abnormal test parameters or other signs of liver disease should be assessed initially by doctors who have experience in liver diseases to determine the ability to cause disease and contributing factors and thereby offer reasonable treatment and prevention interventions.

    Infection of catheter and blood infection:

    Bacterial and bacterial infections may occur due to the use of venous catheter to infect intravenous infusion products, poor maintenance of catheter or due to the use of infected solutions.

    Immune inhibition and other factors such as hyperglycemia, malnutrition and/or pathological status can cause patients to have infection complications.

    Be careful with symptoms and tests such as fever, cheerleading, cold, white blood cells, technical complications with equipment used in treatment, hyperglycemia can help early detect bacterial infections.

    can minimize infections with focus on sterile techniques at the location of the pipe, good maintenance, sterile techniques when producing nutritional products.

    precipitate:

    Precipitation of pulmonary vessels has been reported in patients using intravenous sugars. Some deaths have occurred.

    It is necessary to periodically check the solution, the transmission line, the catheter and the ability to precipitate.

    If there are signs of respiratory failure, it is necessary to stop infusion and make a reasonable assessment.

    Do not infect glucose solution along with blood through a set of lines because it can cause hemolysis and obstruction.

    Pediatric patients:

    Injecting speed and volume of infusion depend on age, weight, clinical condition, patient metabolism, simultaneous treatment and should be decided by a doctor who has experience in using infusion therapy for pediatric patients.

    To avoid death when infusing infusion for babies, it is necessary to be especially cautious about the infusion method, when using the syringe for infusion or medicine for babies, not to connect the fluid bag to the syringe.

    When using an infusion pump, all the clamps on the infusion cable must be locked before removing the transmission line from the transmission pump or turning off the infusion pump. This is required regardless of whether the device has the function of locking the flow.

    Must regularly monitor the transmission line and infusion pumps.

    Issues related to blood sugar in pediatric patients:

    Infants, especially premature babies with low weight, are at risk of increasing or lowering hypoglycemia, so it is necessary to closely monitor during the use of glucose intravenous injection solution to ensure appropriate blood sugar, avoiding potential side effects in the long run.

    Hypoglycemia in newborns can cause prolonged seizures, coma and brain damage. Hyperglycemia is associated with cerebral hemorrhage, bacterial and fungal infections in the late stages, retinal disease due to premature birth, necrotizing bowelitis, bronchial dysplasia, prolonging the time of hospitalization and death.

    Issues related to blood hypoglycet in children:

    Children (including newborns and older children) are at risk of hypoglycemia, as well as sodium hypoglycemia.

    Need to strictly control the electrolyte levels in plasma.

    Quickly recover from hypoglycemia of hypoglycemia causes potential danger (because of the risk of serious neurological complications).

    Used in the geriatric:

    When choosing an infusion solution, the injection speed, the volume of the infusion for the patient of the elderly patients, it is necessary to consider the possibility of diseases such as heart failure, liver failure, kidney failure, other diseases and simultaneous medications.

    The ability to drive and operate machinery

    does not affect driving and operating the machine.

    Pregnancy

    Used for pregnant women, but need to be cautious in labor. Glucose infusion in labor can lead to insulin production in the fetus, which is associated with the risk of hyperglycemia and metabolic acidosis in the fetus as well as the hypoglycemic reaction in newborns.

    breastfeeding period

    Used for nursing women.

    Drug interaction

    Need to calculate the effect of glucose solution on blood sugar and water balance, electrolytes when used for patients who are treating other drugs that control blood sugar, fluid balancing, electrolytes.

    Cavalry:

    Before adding any drug to the glucose solution to transfer, it must be checked to see if it is suitable.

    The solution contains glucose and has a pH

    Storage

    Store at a temperature not exceeding 30 ° C.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords